Trial protocols at the BMJ

BMJ 2004; 329 doi: http://dx.doi.org/10.1136/bmj.329.7479.1360 (Published 9 December 2004)
Cite this as: BMJ 2004;329:1360

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Giselle Jones, assistant editor,
  2. Kamran Abbasi, acting editor
  1. BMJ

    Authors must submit the protocol with the trial

    Moves to improve the conduct and reporting of clinical trials have gathered pace this year. One issue that the BMJ has long grappled with is what to do about protocols of trials, and we announce a new policy that begins in January 2005.

    Medical research should begin with a protocol that details the hypothesis, objectives, and methodology to be used in the study. Ideally the study should not deviate from the protocol, but in reality it often does. Sometimes deviating from the protocol is unavoidable—for example, when new evidence is published independently during the trial which invalidates the specified outcome. In other instances, protocol deviation may represent …

    Get access to this article and all of bmj.com for the next 14 days

    Sign up for a 14 day free trial today

    Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL